Frost & Sullivan recognizes SleepRes Kricket PAP for innovation
By HME News Staff
Updated 8:32 AM CDT, Thu September 17, 2026
SAN ANTONIO – Frost & Sullivan has announced that SleepRes has been recognized with the 2026 North America New Product Innovation Recognition for positive airway pressure devices for its achievements in product innovation, clinical differentiation and patient-centric therapy design. Frost & Sullivan says it evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. "The Kricket PAP device supports KPAP, traditional CPAP, and APAP modes within a single platform,” said Utkarsha Soundankar, industry analyst, Frost & Sullivan. “This multi-mode architecture enables seamless clinician adoption without forcing protocol changes and aligns with existing reimbursement and prescribing frameworks.” Each year, Frost & Sullivan says it presents the New Product Innovation Recognition to a company that demonstrates outstanding development and implementation, resulting in measurable improvements in market impact, product differentiation and competitive positioning.
Comments